Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.

September 15th, 2026

Amber Watters, MD, on counseling patients for external cephalic version

Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.

September 15th, 2026

SMFM: Managing high-risk pregnancies amid abortion care restrictions

SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.

September 11th, 2026

Kevin Ault, MD, on maternal immunization as a bridge to pediatric vaccination

Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.

September 9th, 2026

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.

September 9th, 2026

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

FDA granted BTD to certolizumab pegol for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome.

September 8th, 2026

Amber Watters, MD, on anesthesia in external cephalic version for breech presentation

Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.

September 3rd, 2026

Kevin Ault, MD, on the extended RSV window in ACOG's 2026-27 immunization guidance

Kevin Ault, MD, FACOG, explains ACOG's extension of the maternal RSV vaccine window to March 1 and the role of passive immunity in protecting newborns.